Loading…

L1, β-catenin, and E-cadherin expression in patients with colorectal cancer: Correlation with clinicopathologic features and its prognostic significance

Objective Currently, there are no clinically used/routine biomarkers that accurately predict whether colorectal cancer (CRC) patients will or will not respond to adjuvant chemotherapy. The aim of this study was to investigate L1, β‐catenin, and E‐cadherin expression in patients with CRC and their re...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2010-10, Vol.102 (5), p.433-442
Main Authors: Fang, Qing-Xia, Lü, Liang-Zhong, Yang, Bo, Zhao, Zhong-Sheng, Wu, Yue, Zheng, Xiao-Chun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Currently, there are no clinically used/routine biomarkers that accurately predict whether colorectal cancer (CRC) patients will or will not respond to adjuvant chemotherapy. The aim of this study was to investigate L1, β‐catenin, and E‐cadherin expression in patients with CRC and their relationship to tumor progression, and to identify patients who will respond to chemotherapy. Methods A total of 142 patients who underwent surgical treatment for CRC were chosen retrospectively. The samples from these patients were analyzed by immunohistochemistry. SPSS‐14 program package was used for statistical calculation. Results Expression of L1, β‐catenin, and E‐cadherin were found to be strongly associated with invasion and metastasis of CRC. Cox multivariate analysis results indicated that L1 expression and stage of Dukes could be considered as the independent prognostic factors for survival. Furthermore, our study found that the 5‐year survival rate was the significantly associated with the expression of L1, β‐catenin (normal and ectopic expression), and E‐cadherin for Dukes' stage B (P 
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.21537